港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

維立志博-B

51.700

-0.800-1.52%

成交量：38.62萬

成交額：2,001.64萬

市值：102.88億

市盈率：-25.75

高：52.500

開：52.500

低：51.400

收：52.500

52周最高：83.600

52周最低：48.700

股本：1.99億

香港流通股本：1.53億

量比：0.65

換手率：0.25%

股息：- -

股息率：- -

每股收益(LYR):-2.008

淨資產收益率：--

總資產收益率：--

市淨率：89.10

市盈率(LYR):-25.75

市銷率: - -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

維立志博-B

交易所：

SEHK

成立時間：

2012

員工人數：

192

公司地址：

Building 03,Floor 8,18E, Jialingjiang Street,Nanjing,Jiangsu Province,China

官網：

http://www.leadsbiolabs.com

郵編：

210019

電話：

86 25 8337 8099

傳真：

- -

簡介：

南京維立志博生物科技股份有限公司是一家主要從事發現、開發和商業化治療腫瘤、自身免疫性疾病以及其他嚴重疾病的新療法的中國公司。該公司的主要候選藥物包括LBL-024、LBL-034、LBL-033、LBL-007等。該公司的LBL-024主要用於治療肺外神經內分泌癌（EP-NEC）、小細胞肺癌（SCLC）、膽道癌（BTC）及非小細胞肺癌（NSCLC）、食管鱗狀細胞癌（ESCC）、肝細胞癌（HCC）、胃癌（GC）及其他實體瘤。該公司還開發了專有技術平台，包括LeadsBody平台（CD3 T-cell engager平台）、X-body平台（4-1BB engager平台）以及其他幾個雙特異性抗體及融合蛋白平台。該公司主要在國內市場開展業務。

董事

名稱

職位

康小強

董事長，執行董事，提名委員會主席

左鴻剛

執行董事

賴壽鵬

執行董事

張宏冰

獨立非執行董事，提名委員會委員

杜以龍

獨立非執行董事，薪酬委員會主席，審核委員會委員

杜季柳

獨立非執行董事，薪酬委員會委員，提名委員會委員，審核委員會主席

陳仁海

非執行董事，審核委員會委員

張銀成

非執行董事，薪酬委員會委員

倪佳

非執行董事

金輝

監事會主席，監事

汪舟

監事

李夢薇

監事

股東

名稱

職位

康小強

首席執行官，總經理

凌虹

資深副總裁，首席科學官

左鴻剛

首席財務官，董事會秘書，聯席公司秘書

簡雪艮

聯席公司秘書

賴壽鵬

首席戰略官，執行副總裁

蔡勝利

首席醫學官

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/09887/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"維立志博-B","latestPrice":51.7,"timestamp":1764922148009,"preClose":52.5,"halted":0,"volume":386231,"delay":0,"floatShares":153000000,"shares":199000000,"eps":-2.008042,"marketStatus":"未開盤","change":-0.8,"latestTime":"12-05 16:09:08","open":52.5,"high":52.5,"low":51.4,"amount":20016412,"amplitude":0.020952,"askPrice":51.7,"askSize":18500,"bidPrice":51.4,"bidSize":6500,"shortable":3,"etf":0,"ttmEps":-1.858667,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":0,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":52.5,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.6510337829958496,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":153000000,"roa":"--","roe":"--","lyrEps":-2.008042,"volumeRatio":0.6510337829958496,"shares":199000000,"dividePrice":0,"high":52.5,"amplitude":0.020952,"preClose":52.5,"low":51.4,"week52Low":48.7,"pbRate":"89.10","week52High":83.6,"institutionHeld":0,"latestPrice":51.7,"committee":-0.48,"eps":-2.008042,"divideRate":0,"volume":386231,"delay":0,"ttmEps":-1.858667,"open":52.5,"prevYearClose":35,"prevWeekClose":51.7,"prevMonthClose":53,"prevQuarterClose":69.95,"fiveDayClose":53,"twentyDayClose":58.45,"sixtyDayClose":63.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1762185600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2025-12-05","current":-27.815633,"percent":0.967391,"low":-50.052922,"twenty":-43.110759,"median":-40.854935,"eighty":-36.232015,"high":-31.570392,"avg":-40.015296,"sd":4.19927,"marketCap":10282706060},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240},{"date":"2025-08-01","current":-42.800562,"twenty":-46.836196,"median":-44.399434,"eighty":-42.800562,"marketCap":13535375000},{"date":"2025-08-08","current":-41.931377,"twenty":-45.734702,"median":-43.894587,"eighty":-42.800562,"marketCap":13293671875},{"date":"2025-08-15","current":-42.360797,"twenty":-44.683717,"median":-42.975881,"eighty":-41.70245,"marketCap":13409689375},{"date":"2025-08-22","current":-41.268557,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"marketCap":13022964375},{"date":"2025-08-29","current":-41.462871,"twenty":-44.683717,"median":-42.745269,"eighty":-41.268557,"marketCap":13146747980},{"date":"2025-09-05","current":-41.718992,"twenty":-44.115151,"median":-41.93996,"eighty":-40.603026,"marketCap":13087080440},{"date":"2025-09-12","current":-41.612383,"twenty":-43.894587,"median":-41.766832,"eighty":-40.253447,"marketCap":13077135850},{"date":"2025-09-19","current":-40.406926,"twenty":-43.894587,"median":-41.814673,"eighty":-40.270938,"marketCap":12689296840},{"date":"2025-09-26","current":-39.940552,"twenty":-43.592616,"median":-41.710721,"eighty":-39.940552,"marketCap":12510294220},{"date":"2025-10-03","current":-46.021818,"twenty":-44.124681,"median":-41.829747,"eighty":-40.190868,"marketCap":14449489270},{"date":"2025-10-10","current":-44.344385,"twenty":-44.480118,"median":-41.935668,"eighty":-40.263942,"marketCap":13902536820},{"date":"2025-10-17","current":-41.267963,"twenty":-44.480118,"median":-42.061577,"eighty":-40.352531,"marketCap":12927967000},{"date":"2025-10-24","current":-37.571928,"twenty":-44.331016,"median":-41.888099,"eighty":-40.263942,"marketCap":11774394560},{"date":"2025-10-31","current":-34.030535,"twenty":-44.258383,"median":-41.766832,"eighty":-39.846145,"marketCap":10680489660},{"date":"2025-11-07","current":-37.063837,"twenty":-44.143742,"median":-41.612383,"eighty":-39.421071,"marketCap":11625225710},{"date":"2025-11-14","current":-37.306884,"twenty":-44.026925,"median":-41.504614,"eighty":-38.171485,"marketCap":11734616200},{"date":"2025-11-21","current":-32.263354,"twenty":-43.773799,"median":-41.293984,"eighty":-37.626872,"marketCap":10143481800},{"date":"2025-11-28","current":-33.407237,"twenty":-43.416049,"median":-41.25873,"eighty":-37.278832,"marketCap":10541265400},{"date":"2025-12-05","current":-32.531883,"twenty":-43.110759,"median":-40.854935,"eighty":-36.232015,"marketCap":10282706060}],"updateTime":1765108818537},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":382287439,"yearFounded":2012,"employeeNum":192,"address":"Building 03,Floor 8,18E, Jialingjiang Street,Nanjing,Jiangsu Province,China","zipCode":"210019","officePhone":"86 25 8337 8099"},"stockCompanyDetail":{"websiteUrl":"http://www.leadsbiolabs.com","stockEarnings":[{"period":"1week","weight":-0.0245},{"period":"1month","weight":-0.0817},{"period":"3month","weight":-0.2143},{"period":"6month","weight":0.4771},{"period":"ytd","weight":0.4771}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恆生指數"},"description":"南京維立志博生物科技股份有限公司是一家主要從事發現、開發和商業化治療腫瘤、自身免疫性疾病以及其他嚴重疾病的新療法的中國公司。該公司的主要候選藥物包括LBL-024、LBL-034、LBL-033、LBL-007等。該公司的LBL-024主要用於治療肺外神經內分泌癌（EP-NEC）、小細胞肺癌（SCLC）、膽道癌（BTC）及非小細胞肺癌（NSCLC）、食管鱗狀細胞癌（ESCC）、肝細胞癌（HCC）、胃癌（GC）及其他實體瘤。該公司還開發了專有技術平台，包括LeadsBody平台（CD3 T-cell engager平台）、X-body平台（4-1BB engager平台）以及其他幾個雙特異性抗體及融合蛋白平台。該公司主要在國內市場開展業務。","exchange":"SEHK","name":"維立志博-B","nameEN":"LEADS BIOLABS-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":{"directors":[{"name":"康小強","position":"董事長，執行董事，提名委員會主席"},{"name":"左鴻剛","position":"執行董事"},{"name":"賴壽鵬","position":"執行董事"},{"name":"張宏冰","position":"獨立非執行董事，提名委員會委員"},{"name":"杜以龍","position":"獨立非執行董事，薪酬委員會主席，審核委員會委員"},{"name":"杜季柳","position":"獨立非執行董事，薪酬委員會委員，提名委員會委員，審核委員會主席"},{"name":"陳仁海","position":"非執行董事，審核委員會委員"},{"name":"張銀成","position":"非執行董事，薪酬委員會委員"},{"name":"倪佳","position":"非執行董事"},{"name":"金輝","position":"監事會主席，監事"},{"name":"汪舟","position":"監事"},{"name":"李夢薇","position":"監事"}],"executives":[{"name":"康小強","position":"首席執行官，總經理"},{"name":"凌虹","position":"資深副總裁，首席科學官"},{"name":"左鴻剛","position":"首席財務官，董事會秘書，聯席公司秘書"},{"name":"簡雪艮","position":"聯席公司秘書"},{"name":"賴壽鵬","position":"首席戰略官，執行副總裁"},{"name":"蔡勝利","position":"首席醫學官"}]}}}